Idrees Muhammad Mubashar, Rasool Muhammad Fawad, Imran Imran, Khalid Ayesha, Saeed Ali, Ahmad Tanveer, Alqahtani Faleh
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, 60800, Pakistan.
Multan Institute of Kidney Diseases (MIKD), Multan, Pakistan.
Infect Drug Resist. 2022 Apr 15;15:1845-1855. doi: 10.2147/IDR.S356489. eCollection 2022.
Urinary tract infections (UTIs) are a common infection caused by uropathogenic bacteria. Drug resistance against common antibiotics is a leading cause of treatment failure in UTIs.
This study was conducted to check the prevalence of antimicrobial susceptibility against uropathogens and identify the best treatment option against UTIs.
In this cross-sectional study, urine samples (n = 1000) were collected and cultured for pure bacterial growth by using cysteine-lactose-electrolyte-deficient (CLED) media. After physical and biochemical characterization, antibacterial susceptibility was performed by the Kirby-Bauer disk diffusion method.
Uropathogenic bacteria were successfully isolated in 57% (n = 572) of total tested samples (n = 1000). 51.2% (n = 293/572), species 15.4% (n = 88/572), species 15.4% (n = 88/572), species 9.4% (n = 54/572), 3.2% (n = 18/572), coagulase-negative (CoNS) 3.0% (n = 17/572) and species 2.4% (n = 14/572) were the most prevalent organism in UTIs. Prevalence of Gram-negative rods (GNRs) was 78.5% (n = 449/572) among UTI patients as compared to Gram-positive cocci (GPCs) 21.5% (n = 123/572). 65.3% (n = 293/449), species 19.6% (n = 88/449), species 12.0% (54/449) and species 3.1% (n = 14/449) were the most prevalent GNRs in UTIs, while species 71.5% (n = 88/123), 14.6% (n = 18/123) and coagulase-negative (CoNS) 13.8% (17/123) were the most prevalent GPCs in UTIs. The majority of isolated uropathogens showed resistance against routinely used antibiotics. However, teicoplanin and linezolid were the most effective drugs against GPCs and piperacillin/tazobactam, meropenem and imipenem were the most effective drugs against GNRs. Nitrofurantoin and fosfomycin were shown to be most effective against both GNRs and GPCs.
In conclusion, (GNRs) and species (GPCs) are the most prevalent organisms among UTIs patients, which are shown to be antibiotic-resistant to the most commonly used antibiotics. However, nitrofurantoin and fosfomycin are the most effective drugs against uropathogens in UTIs.
尿路感染(UTIs)是由尿路致病性细菌引起的常见感染。对常用抗生素的耐药性是UTIs治疗失败的主要原因。
本研究旨在检测尿路病原体对抗菌药物的敏感性,并确定UTIs的最佳治疗方案。
在这项横断面研究中,收集了1000份尿液样本,使用半胱氨酸-乳糖-电解质缺乏(CLED)培养基进行培养以获得纯细菌生长。经过物理和生化鉴定后,采用 Kirby-Bauer 纸片扩散法进行抗菌药物敏感性检测。
在总共1000份检测样本中,57%(n = 572)成功分离出尿路致病性细菌。大肠埃希菌占51.2%(n = 293/572),肺炎克雷伯菌占15.4%(n = 88/572),奇异变形杆菌占15.4%(n = 88/572),粪肠球菌占9.4%(n = 54/572),金黄色葡萄球菌占3.2%(n = 18/572),凝固酶阴性葡萄球菌(CoNS)占3.0%(n = 17/572),腐生葡萄球菌占2.4%(n = 14/572)是UTIs中最常见的病原体。UTI患者中革兰氏阴性杆菌(GNRs)的比例为78.5%(n = 449/572),而革兰氏阳性球菌(GPCs)为21.5%(n = 123/572)。大肠埃希菌占65.3%(n = 293/449),肺炎克雷伯菌占19.6%(n = 88/449),奇异变形杆菌占12.0%(54/449),腐生葡萄球菌占3.1%(n = 14/449)是UTIs中最常见的GNRs,而金黄色葡萄球菌占71.5%(n = 88/123),表皮葡萄球菌占14.6%(n = 18/123),凝固酶阴性葡萄球菌(CoNS)占13.8%(17/123)是UTIs中最常见的GPCs。大多数分离出的尿路病原体对常用抗生素耐药。然而,替考拉宁和利奈唑胺是对抗GPCs最有效的药物,哌拉西林/他唑巴坦、美罗培南和亚胺培南是对抗GNRs最有效的药物。呋喃妥因和磷霉素对GNRs和GPCs均显示出最有效。
总之,革兰氏阴性杆菌(GNRs)和金黄色葡萄球菌(GPCs)是UTI患者中最常见的病原体,它们对最常用的抗生素具有耐药性。然而,呋喃妥因和磷霉素是UTIs中对抗尿路病原体最有效的药物。